GB9925490D0 - Binding molecules and treatment and screening methods - Google Patents

Binding molecules and treatment and screening methods

Info

Publication number
GB9925490D0
GB9925490D0 GBGB9925490.6A GB9925490A GB9925490D0 GB 9925490 D0 GB9925490 D0 GB 9925490D0 GB 9925490 A GB9925490 A GB 9925490A GB 9925490 D0 GB9925490 D0 GB 9925490D0
Authority
GB
United Kingdom
Prior art keywords
treatment
binding molecules
screening methods
screening
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9925490.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd CUTS
Original Assignee
Cambridge University Technical Services Ltd CUTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Technical Services Ltd CUTS filed Critical Cambridge University Technical Services Ltd CUTS
Priority to GBGB9925490.6A priority Critical patent/GB9925490D0/en
Publication of GB9925490D0 publication Critical patent/GB9925490D0/en
Priority to PCT/GB2000/004171 priority patent/WO2001030852A1/en
Priority to AU11541/01A priority patent/AU1154101A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB9925490.6A 1999-10-28 1999-10-28 Binding molecules and treatment and screening methods Ceased GB9925490D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9925490.6A GB9925490D0 (en) 1999-10-28 1999-10-28 Binding molecules and treatment and screening methods
PCT/GB2000/004171 WO2001030852A1 (en) 1999-10-28 2000-10-30 Production of immunoglobulins which binds heterologous fcr with modified affinity
AU11541/01A AU1154101A (en) 1999-10-28 2000-10-30 Production of immunoglobulins which binds heterologous fcr with modified affinity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9925490.6A GB9925490D0 (en) 1999-10-28 1999-10-28 Binding molecules and treatment and screening methods

Publications (1)

Publication Number Publication Date
GB9925490D0 true GB9925490D0 (en) 1999-12-29

Family

ID=10863522

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9925490.6A Ceased GB9925490D0 (en) 1999-10-28 1999-10-28 Binding molecules and treatment and screening methods

Country Status (3)

Country Link
AU (1) AU1154101A (en)
GB (1) GB9925490D0 (en)
WO (1) WO2001030852A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010298264B2 (en) * 2009-09-24 2014-10-23 Xbiotech Inc. Methods, compositions, and kits for reducing anti-antibody responses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105245D0 (en) * 1991-03-12 1991-04-24 Lynxvale Ltd Binding molecules

Also Published As

Publication number Publication date
WO2001030852A1 (en) 2001-05-03
AU1154101A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
EP1157275A4 (en) Novel transduction molecules and methods for using same
HK1051010A1 (en) Filter arrangement and methods
EP1355715A4 (en) Filter apparatus and methods
EP1208721A4 (en) Improved crossover filters and method
EP1223932A4 (en) Compounds and methods
EP1146790A4 (en) Compounds and methods
AP2000001847A0 (en) Anti-counterfeiting method and apparatus using digtal screening
EP1169165A4 (en) Agglomerating and drying apparatus
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
GB2375735B (en) Binding apparatus
GB9919482D0 (en) Waste treatment apparatus and methods
AUPP828699A0 (en) Drying apparatus and methods
AU2006902A (en) Methods and instruments for treating pseudoarthrosis
HUP0201966A2 (en) Methods of treatment and drug screening methods
GB2361644B (en) Waste treatment apparatus and methods
GB9925679D0 (en) Novel process and apparatus
GB9925747D0 (en) Leaf destruction method and apparatus
GB9925490D0 (en) Binding molecules and treatment and screening methods
EP1112250A4 (en) Therapeutic compounds and methods
AU5169200A (en) Methods and compositions for treating breakthrough pain
GB9805045D0 (en) Treatment process and apparatus
EP1071434A4 (en) Cnre binding factors and uses thereof
EP1229924A4 (en) Targeted bifunctional molecules and therapies based thereon
GB9813917D0 (en) Histamine and serotonin binding molecules
GB9814878D0 (en) Methods and apparatus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)